TCRT Earnings Alaunos Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Quarterly results
EPS
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | -0.85 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.59 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -2.20 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -1.84 | 2025-11-14 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.30 | 2026-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.67 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -2.92 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -2.46 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.75 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.05 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -21.97 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -17.07 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -11.78 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.63 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -2.61 | 2024-04-01 | 10-K |
| Q3 2023 | 2022-09-30 | -0.13 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.09 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.05 | 2023-05-10 | 10-Q |
| FY 2022 | 2021-12-31 | -0.37 | 2023-03-07 | 10-K |
| Q3 2022 | 2021-09-30 | -0.31 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.21 | 2022-08-15 | 10-Q |
| FY 2020 | 2020-12-31 | -0.38 | 2021-03-01 | 10-K |
| FY 2020 | 2020-09-30 | -0.10 | 2021-03-01 | 10-K |
| FY 2020 | 2020-06-30 | -0.09 | 2021-03-01 | 10-K |
| FY 2020 | 2020-03-31 | -0.09 | 2021-03-01 | 10-K |
| FY 2020 | 2019-12-31 | -0.70 | 2021-03-01 | 10-K |
| FY 2020 | 2019-09-30 | -0.43 | 2021-03-01 | 10-K |
| FY 2020 | 2019-06-30 | -0.09 | 2021-03-01 | 10-K |
| FY 2020 | 2019-03-31 | -0.08 | 2021-03-01 | 10-K |
| FY 2020 | 2018-12-31 | 0.96 | 2021-03-01 | 10-K |
| FY 2019 | 2018-09-30 | -0.13 | 2020-03-02 | 10-K |
| FY 2019 | 2018-06-30 | -0.12 | 2020-03-02 | 10-K |
| FY 2019 | 2018-03-31 | -0.15 | 2020-03-02 | 10-K |
| FY 2019 | 2017-12-31 | -0.53 | 2020-03-02 | 10-K |
| FY 2018 | 2016-12-31 | -1.32 | 2019-03-05 | 10-K |
| Q3 2012 | 2012-09-30 | -0.85 | 2012-11-08 | 10-Q |
| Q3 2012 | 2011-09-30 | -0.77 | 2012-11-08 | 10-Q |
| Q3 2011 | 2010-09-30 | -0.48 | 2011-11-03 | 10-Q |
| Q3 2010 | 2009-09-30 | -0.40 | 2011-08-01 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.